NM_003238.6:c.-677T>C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_003238.6(TGFB2):​c.-677T>C variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.385 in 150,444 control chromosomes in the GnomAD database, including 13,242 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.39 ( 13242 hom., cov: 28)

Consequence

TGFB2
NM_003238.6 5_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.257

Publications

5 publications found
Variant links:
Genes affected
TGFB2 (HGNC:11768): (transforming growth factor beta 2) This gene encodes a secreted ligand of the TGF-beta (transforming growth factor-beta) superfamily of proteins. Ligands of this family bind various TGF-beta receptors leading to recruitment and activation of SMAD family transcription factors that regulate gene expression. The encoded preproprotein is proteolytically processed to generate a latency-associated peptide (LAP) and a mature peptide, and is found in either a latent form composed of a mature peptide homodimer, a LAP homodimer, and a latent TGF-beta binding protein, or in an active form consisting solely of the mature peptide homodimer. The mature peptide may also form heterodimers with other TGF-beta family members. Disruption of the TGF-beta/SMAD pathway has been implicated in a variety of human cancers. A chromosomal translocation that includes this gene is associated with Peters' anomaly, a congenital defect of the anterior chamber of the eye. Mutations in this gene may be associated with Loeys-Dietz syndrome. This gene encodes multiple isoforms that may undergo similar proteolytic processing. [provided by RefSeq, Aug 2016]
TGFB2-AS1 (HGNC:50628): (TGFB2 antisense RNA 1 (head to head))

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.61).
BP6
Variant 1-218346025-T-C is Benign according to our data. Variant chr1-218346025-T-C is described in ClinVar as Benign. ClinVar VariationId is 295468.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.639 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_003238.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TGFB2
NM_003238.6
MANE Select
c.-677T>C
5_prime_UTR
Exon 1 of 7NP_003229.1P61812-1
TGFB2
NM_001135599.4
c.-677T>C
5_prime_UTR
Exon 1 of 8NP_001129071.1P61812-2
TGFB2
NR_138148.2
n.690T>C
non_coding_transcript_exon
Exon 1 of 7

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TGFB2
ENST00000366930.9
TSL:1 MANE Select
c.-677T>C
5_prime_UTR
Exon 1 of 7ENSP00000355897.4P61812-1
TGFB2-AS1
ENST00000414452.3
TSL:3
n.26A>G
non_coding_transcript_exon
Exon 1 of 3
TGFB2-AS1
ENST00000689961.3
n.18A>G
non_coding_transcript_exon
Exon 1 of 3

Frequencies

GnomAD3 genomes
AF:
0.385
AC:
57841
AN:
150336
Hom.:
13210
Cov.:
28
show subpopulations
Gnomad AFR
AF:
0.646
Gnomad AMI
AF:
0.338
Gnomad AMR
AF:
0.297
Gnomad ASJ
AF:
0.316
Gnomad EAS
AF:
0.377
Gnomad SAS
AF:
0.347
Gnomad FIN
AF:
0.312
Gnomad MID
AF:
0.337
Gnomad NFE
AF:
0.268
Gnomad OTH
AF:
0.348
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.385
AC:
57932
AN:
150444
Hom.:
13242
Cov.:
28
AF XY:
0.383
AC XY:
28142
AN XY:
73460
show subpopulations
African (AFR)
AF:
0.646
AC:
26304
AN:
40732
American (AMR)
AF:
0.297
AC:
4510
AN:
15200
Ashkenazi Jewish (ASJ)
AF:
0.316
AC:
1093
AN:
3460
East Asian (EAS)
AF:
0.377
AC:
1866
AN:
4954
South Asian (SAS)
AF:
0.348
AC:
1652
AN:
4752
European-Finnish (FIN)
AF:
0.312
AC:
3248
AN:
10426
Middle Eastern (MID)
AF:
0.359
AC:
104
AN:
290
European-Non Finnish (NFE)
AF:
0.268
AC:
18112
AN:
67626
Other (OTH)
AF:
0.351
AC:
737
AN:
2098
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
1454
2908
4361
5815
7269
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
524
1048
1572
2096
2620
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.329
Hom.:
1197
Bravo
AF:
0.399
Asia WGS
AF:
0.364
AC:
1263
AN:
3474

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
Loeys-Dietz syndrome 4 (1)
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.61
CADD
Benign
20
DANN
Benign
0.67
PhyloP100
0.26
PromoterAI
0.096
Neutral

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs112369231; hg19: chr1-218519367; API